A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 07 Aug 2021